Glenmede Trust CO Na Blueprint Medicines Corp Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
A detailed history of Glenmede Trust CO Na transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 3,162 shares of BPMC stock, worth $409,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,162Holding current value
$409,352% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding BPMC
# of Institutions
46Shares Held
8.67MCall Options Held
8Put Options Held
151K-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8724KShares$93.7 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...